Your browser doesn't support javascript.
loading
Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2.
Routledge, Isobel; Takahashi, Saki; Epstein, Adrienne; Hakim, Jill; Janson, Owen; Turcios, Keirstinne; Vinden, Jo; Risos, John Tomas; Baniqued, Margaret Rose; Pham, Lori; Di Germanio, Clara; Busch, Michael; Kushel, Margot; Greenhouse, Bryan; Rodríguez-Barraquer, Isabel.
Afiliação
  • Routledge I; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. isobel.routledge@ucsf.edu.
  • Takahashi S; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. saki.takahashi@ucsf.edu.
  • Epstein A; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Hakim J; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Janson O; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Turcios K; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Vinden J; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Risos JT; Infectious Disease and Immunity Graduate Group, University of California Berkeley, Berkeley, CA, USA.
  • Baniqued MR; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Pham L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Di Germanio C; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Busch M; Vitalant Research Institute, San Francisco, CA, USA.
  • Kushel M; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Greenhouse B; Vitalant Research Institute, San Francisco, CA, USA.
  • Rodríguez-Barraquer I; Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA, USA.
Nat Commun ; 13(1): 2451, 2022 05 04.
Article em En | MEDLINE | ID: mdl-35508478

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos